Department of Public Health, POB 41, University of Helsinki, Mannerheimintie 172, FIN-00014 Helsinki, Finland.
Allergy Asthma Clin Immunol. 2013 Nov 26;9(1):46. doi: 10.1186/1710-1492-9-46.
Asthma exacerbations are often induced by the common cold, which, in turn, can be alleviated by vitamin C.
To investigate whether vitamin C administration influences common cold-induced asthma.
Systematic review and statistical analysis of the identified trials. Medline, Scopus and Cochrane Central were searched for studies that give information on the effects of vitamin C on common cold-induced asthma. All clinically relevant outcomes related to asthma were included in this review. The estimates of vitamin C effect and their confidence intervals [CI] were calculated for the included studies.
Three studies that were relevant for examining the role of vitamin C on common cold-induced asthma were identified. The three studies had a total of 79 participants. Two studies were randomized double-blind placebo-controlled trials. A study in Nigeria on asthmatics whose asthma attacks were precipitated by respiratory infections found that 1 g/day vitamin C decreased the occurrence of asthma attacks by 78% (95% CI: 19% to 94%). A cross-over study in former East-Germany on patients who had infection-related asthma found that 5 g/day vitamin C decreased the proportion of participants who had bronchial hypersensitivity to histamine by 52 percentage points (95% CI: 25 to 71). The third study did not use a placebo. Administration of a single dose of 1 gram of vitamin C to Italian non-asthmatic common cold patients increased the provocative concentration of histamine (PC20) 3.2-fold (95% CI: 2.0 to 5.1), but the vitamin C effect was significantly less when the same participants did not suffer from the common cold.
The three reviewed studies differed substantially in their methods, settings and outcomes. Each of them found benefits from the administration of vitamin C; either against asthma attacks or against bronchial hypersensitivity, the latter of which is a characteristic of asthma. Given the evidence suggesting that vitamin C alleviates common cold symptoms and the findings of this systematic review, it may be reasonable for asthmatic patients to test vitamin C on an individual basis, if they have exacerbations of asthma caused by respiratory infections. More research on the role of vitamin C on common cold-induced asthma is needed.
哮喘加重通常由普通感冒引起,而感冒又可以通过维生素 C 得到缓解。
研究维生素 C 的摄入是否会影响普通感冒引起的哮喘。
对已确定的试验进行系统评价和统计分析。在 Medline、Scopus 和 Cochrane Central 中检索了有关维生素 C 对普通感冒引起的哮喘影响的研究。本综述纳入了所有与哮喘相关的临床相关结局。对纳入的研究计算了维生素 C 效应的估计值及其置信区间[CI]。
确定了三项关于维生素 C 对普通感冒引起的哮喘作用的相关研究。这三项研究共有 79 名参与者。其中两项研究是随机双盲安慰剂对照试验。尼日利亚的一项研究针对的是哮喘患者,他们的哮喘发作是由呼吸道感染引发的,研究发现每天摄入 1 克维生素 C 可使哮喘发作的发生率降低 78%(95%CI:19%至 94%)。前东德的一项交叉研究针对的是与感染相关的哮喘患者,发现每天摄入 5 克维生素 C 可使参与者对组织胺的支气管高反应性降低 52 个百分点(95%CI:25 至 71)。第三项研究未使用安慰剂。意大利非哮喘普通感冒患者单次给予 1 克维生素 C 可使组织胺激发浓度(PC20)增加 3.2 倍(95%CI:2.0 至 5.1),但当相同的参与者未患普通感冒时,维生素 C 的效果显著降低。
这三项已审查的研究在方法、环境和结局方面存在显著差异。它们中的每一项都发现了维生素 C 的益处;要么对抗哮喘发作,要么对抗支气管高反应性,后者是哮喘的特征。鉴于维生素 C 可缓解普通感冒症状的证据,以及本系统评价的结果,对于因呼吸道感染而使哮喘加重的哮喘患者,基于个体情况测试维生素 C 可能是合理的。需要进一步研究维生素 C 在普通感冒引起的哮喘中的作用。